Review
Published on 15 Jun 2023
Pharmacological approaches to pulmonary fibrosis following COVID-19
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1143158
- 10,157 views
- 16 citations
Type at least 3 characters
485 articles
Correction
Published on 12 Jun 2023
Corrigendum: Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1228923
- 1,485 views
Original Research
Published on 09 Jun 2023
Bronchoscopic instillation of amphotericin B is a safe and effective measure to treat pulmonary mycosis
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1167475
- 5,597 views
- 8 citations
Original Research
Published on 02 Jun 2023
Elexacaftor-tezacaftor-ivacaftor in patients with cystic fibrosis ineligible for clinical trials: a 24-week observational study
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1178009
- 2,012 views
- 1 citation
Review
Published on 26 May 2023
Landscape analysis and overview of the literature on oxidative stress and pulmonary diseases
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1190817
- 5,571 views
- 14 citations
Review
Published on 23 May 2023
Comparative efficacy and acceptability of licensed dose intranasal corticosteroids for moderate-to-severe allergic rhinitis: a systematic review and network meta-analysis
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1184552
- 15,119 views
- 7 citations
Original Research
Published on 22 May 2023
STC3141 improves acute lung injury through neutralizing circulating histone in rat with experimentally-induced acute respiratory distress syndrome
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1166814
- 3,311 views
- 6 citations
Original Research
Published on 19 May 2023
Herb-symptom analysis of Erchen decoction combined with Xiebai powder formula and its mechanism in the treatment of chronic obstructive pulmonary disease
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1117238
- 4,354 views
- 6 citations
Original Research
Published on 18 May 2023
The identification of metabolism-related subtypes and potential treatments for idiopathic pulmonary fibrosis
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1173961
- 3,978 views
- 3 citations
Review
Published on 16 May 2023
Perspectives on precision cut lung slices—powerful tools for investigation of mechanisms and therapeutic targets in lung diseases
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1162889
- 11,612 views
- 28 citations
Review
Published on 11 May 2023
Herbal medicine for the treatment of obesity-associated asthma: a comprehensive review
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1186060
- 7,856 views
- 7 citations
Original Research
Published on 05 May 2023
Efficacy of a paper-based interleukin-6 test strip combined with a spectrum-based optical reader for sequential monitoring and early recognition of respiratory failure in elderly pneumonia—a pilot study
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1166923
- 2,752 views
- 1 citation
Case Report
Published on 04 May 2023
Case Report: Nintedanib for immune-related pneumonitis triggered by anti-PD-1 treatment in a patient with SMARCA4-mutant NSCLC: a case report
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1177329
- 2,993 views
- 2 citations
Correction
Published on 03 May 2023
Corrigendum: Elexacaftor-Tezacaftor-Ivacaftor treatment reduces abdominal symptoms in cystic fibrosis-early results obtained with the CF-specific CFAbd-Score
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1207356
- 1,425 views
Original Research
Published on 24 Apr 2023
Survivin inhibition with YM155 ameliorates experimental pulmonary arterial hypertension
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1145994
- 3,627 views
- 4 citations
Original Research
Published on 17 Apr 2023
The performance of metagenomic next-generation sequencing in diagnosing pulmonary infectious diseases using authentic clinical specimens: The Illumina platform versus the Beijing Genomics Institute platform
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1164633
- 3,126 views
- 2 citations